The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review

Published:2021-01 Issue: Volume:Volume 13 Page:1-12
ISSN:1179-1438
Container-title:Clinical Pharmacology: Advances and Applications
language:en
Short-container-title:CPAA

Author:

Sileshi Tesemma,Tadesse Esayas^ORCID,Makonnen Eyasu,Aklillu Eleni^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical)

Reference44 articles.

1. WHO. Global Tuberculosis Report; 2019.

2. WHO. End TB Strategy; 2015.

3. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring

4. Understanding pharmacokinetics to improve tuberculosis treatment outcome

5. Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete neurological recovery of spinal tuberculosis after spinal surgery and vitamin D supplementary: A case series;International Journal of Surgery Case Reports;2024-09

2. Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-17

3. Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis;Clinical Infectious Diseases;2024-03-11

4. Variability in plasma rifampicin concentrations and role of SLCO1B1 , ABCB1 , AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis;Infectious Diseases;2024-02-05

5. Green synthesis trends and potential applications of bimetallic nanoparticles towards the sustainable development goals 2030;Nanoscale Advances;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3